Brunner J, Schvartz D, Gouiller A, Hainard A, Borchard G. Impact of peptide permeation enhancer on tight junctions opening cellular mechanisms.
Biochem Biophys Rep 2022;
32:101375. [PMID:
36324528 PMCID:
PMC9618981 DOI:
10.1016/j.bbrep.2022.101375]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Revised: 10/03/2022] [Accepted: 10/24/2022] [Indexed: 11/09/2022] Open
Abstract
The myristoylated pentapeptide, L-R5, contains an amino acid sequence of the zeta inhibitory peptide (ZIP) portion (pseudosubstrate) of protein kinase C zeta (PKC ζ). As PKC ζ is involved in the modulation of epithelial tight junctions (TJs) through the phosphorylation of TJ proteins, L-R5 was suggested to interact with the enzyme resulting in the enhancement of paracellular permeability. This study shows that L-R5 does not bind to the enzyme but interacts directly with TJ proteins. We show here that the binding of PKC ζ to occludin and its successive phosphorylation is prevented by L-R5, which leads to TJ disruption and enhanced epithelial permeability. Although L-R5 did not show any in vitro cytotoxicity, a proteomics study revealed that L-R5 interferes with other regulatory pathways, e.g., apoptosis and immune response. We suggest that structural modification of the peptide may increase the specificity TJ protein-peptide interaction.
Microscale thermophoresis (MST) showed robust results for protein bindings.
The competitivity of L-R5 peptide for the binding of occludin-PKC zeta was shown.
Tight junctions proteins expression was decreased due to L-R5 peptide.
Multiple other mechanisms can be explored to use L-R5 for other therapies.
Collapse